Molecular subtype-specific expression of MicroRNA-29c in breast cancer is associated with CpG dinucleotide methylation of the promoter

Elizabeth Poli, Jing Zhang, Chika Nwachukwu, Yonglan Zheng, Babatunde Adedokun, Olufunmilayo I. Olopade, Yoo Jeong Han

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Basal-like breast cancer is a molecularly distinct subtype of breast cancer that is highly aggressive and has a poor prognosis. MicroRNA-29c (miR-29c) has been shown to be significantly down-regulated in basal-like breast tumors and to be involved in cell invasion and sensitivity to chemotherapy. However, little is known about the genetic and regulatory factors contributing to the altered expression of miR-29c in basal-like breast cancer. We here report that epigenetic modifications at the miR-29c promoter, rather than copy number variation of the gene, may drive the lower expression of miR-29c in basal-like breast cancer. Bisulfite sequencing of CpG sites in the miR-29c promoter region showed higher methylation in basal-like breast cancer cell lines compared to luminal subtype cells with a significant inverse correlation between expression and methylation of miR-29c. Analysis of primary breast tumors using The Cancer Genome Atlas (TCGA) dataset confirmed significantly higher levels of methylation of the promoter in basal-like breast tumors compared to all other subtypes. Furthermore, inhibition of CpG methylation with 5-aza-CdR increases miR-29c expression in basal-like breast cancer cells. Flourescent In Situ Hybridization (FISH) revealed chromosomal abnormalities at miR-29c loci in breast cancer cell lines, but with no correlation between copy number variation and expression of miR-29c. Our data demonstrated that dysregulation of miR-29c in basal-like breast cancer cells may be in part driven by methylation at CpG sites. Epigenetic control of the miR-29c promoter by epigenetic modifiers may provide a potential therapeutic target to overcome the aggressive behavior of these cancers.

Original languageEnglish (US)
Article numbere0142224
JournalPloS one
Volume10
Issue number11
DOIs
StatePublished - Nov 5 2015
Externally publishedYes

Fingerprint

Methylation
MicroRNAs
microRNA
methylation
breast neoplasms
promoter regions
Breast Neoplasms
Cells
Epigenomics
epigenetics
Tumors
Genes
cell lines
Cell Line
bisulfites
neoplasms
cell invasion
modifiers (genes)
Chemotherapy
Gene Dosage

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Cite this

Molecular subtype-specific expression of MicroRNA-29c in breast cancer is associated with CpG dinucleotide methylation of the promoter. / Poli, Elizabeth; Zhang, Jing; Nwachukwu, Chika; Zheng, Yonglan; Adedokun, Babatunde; Olopade, Olufunmilayo I.; Han, Yoo Jeong.

In: PloS one, Vol. 10, No. 11, e0142224, 05.11.2015.

Research output: Contribution to journalArticle

Poli, Elizabeth ; Zhang, Jing ; Nwachukwu, Chika ; Zheng, Yonglan ; Adedokun, Babatunde ; Olopade, Olufunmilayo I. ; Han, Yoo Jeong. / Molecular subtype-specific expression of MicroRNA-29c in breast cancer is associated with CpG dinucleotide methylation of the promoter. In: PloS one. 2015 ; Vol. 10, No. 11.
@article{1ef82f29626944d9b322e7ec06ed9c8f,
title = "Molecular subtype-specific expression of MicroRNA-29c in breast cancer is associated with CpG dinucleotide methylation of the promoter",
abstract = "Basal-like breast cancer is a molecularly distinct subtype of breast cancer that is highly aggressive and has a poor prognosis. MicroRNA-29c (miR-29c) has been shown to be significantly down-regulated in basal-like breast tumors and to be involved in cell invasion and sensitivity to chemotherapy. However, little is known about the genetic and regulatory factors contributing to the altered expression of miR-29c in basal-like breast cancer. We here report that epigenetic modifications at the miR-29c promoter, rather than copy number variation of the gene, may drive the lower expression of miR-29c in basal-like breast cancer. Bisulfite sequencing of CpG sites in the miR-29c promoter region showed higher methylation in basal-like breast cancer cell lines compared to luminal subtype cells with a significant inverse correlation between expression and methylation of miR-29c. Analysis of primary breast tumors using The Cancer Genome Atlas (TCGA) dataset confirmed significantly higher levels of methylation of the promoter in basal-like breast tumors compared to all other subtypes. Furthermore, inhibition of CpG methylation with 5-aza-CdR increases miR-29c expression in basal-like breast cancer cells. Flourescent In Situ Hybridization (FISH) revealed chromosomal abnormalities at miR-29c loci in breast cancer cell lines, but with no correlation between copy number variation and expression of miR-29c. Our data demonstrated that dysregulation of miR-29c in basal-like breast cancer cells may be in part driven by methylation at CpG sites. Epigenetic control of the miR-29c promoter by epigenetic modifiers may provide a potential therapeutic target to overcome the aggressive behavior of these cancers.",
author = "Elizabeth Poli and Jing Zhang and Chika Nwachukwu and Yonglan Zheng and Babatunde Adedokun and Olopade, {Olufunmilayo I.} and Han, {Yoo Jeong}",
year = "2015",
month = "11",
day = "5",
doi = "10.1371/journal.pone.0142224",
language = "English (US)",
volume = "10",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "11",

}

TY - JOUR

T1 - Molecular subtype-specific expression of MicroRNA-29c in breast cancer is associated with CpG dinucleotide methylation of the promoter

AU - Poli, Elizabeth

AU - Zhang, Jing

AU - Nwachukwu, Chika

AU - Zheng, Yonglan

AU - Adedokun, Babatunde

AU - Olopade, Olufunmilayo I.

AU - Han, Yoo Jeong

PY - 2015/11/5

Y1 - 2015/11/5

N2 - Basal-like breast cancer is a molecularly distinct subtype of breast cancer that is highly aggressive and has a poor prognosis. MicroRNA-29c (miR-29c) has been shown to be significantly down-regulated in basal-like breast tumors and to be involved in cell invasion and sensitivity to chemotherapy. However, little is known about the genetic and regulatory factors contributing to the altered expression of miR-29c in basal-like breast cancer. We here report that epigenetic modifications at the miR-29c promoter, rather than copy number variation of the gene, may drive the lower expression of miR-29c in basal-like breast cancer. Bisulfite sequencing of CpG sites in the miR-29c promoter region showed higher methylation in basal-like breast cancer cell lines compared to luminal subtype cells with a significant inverse correlation between expression and methylation of miR-29c. Analysis of primary breast tumors using The Cancer Genome Atlas (TCGA) dataset confirmed significantly higher levels of methylation of the promoter in basal-like breast tumors compared to all other subtypes. Furthermore, inhibition of CpG methylation with 5-aza-CdR increases miR-29c expression in basal-like breast cancer cells. Flourescent In Situ Hybridization (FISH) revealed chromosomal abnormalities at miR-29c loci in breast cancer cell lines, but with no correlation between copy number variation and expression of miR-29c. Our data demonstrated that dysregulation of miR-29c in basal-like breast cancer cells may be in part driven by methylation at CpG sites. Epigenetic control of the miR-29c promoter by epigenetic modifiers may provide a potential therapeutic target to overcome the aggressive behavior of these cancers.

AB - Basal-like breast cancer is a molecularly distinct subtype of breast cancer that is highly aggressive and has a poor prognosis. MicroRNA-29c (miR-29c) has been shown to be significantly down-regulated in basal-like breast tumors and to be involved in cell invasion and sensitivity to chemotherapy. However, little is known about the genetic and regulatory factors contributing to the altered expression of miR-29c in basal-like breast cancer. We here report that epigenetic modifications at the miR-29c promoter, rather than copy number variation of the gene, may drive the lower expression of miR-29c in basal-like breast cancer. Bisulfite sequencing of CpG sites in the miR-29c promoter region showed higher methylation in basal-like breast cancer cell lines compared to luminal subtype cells with a significant inverse correlation between expression and methylation of miR-29c. Analysis of primary breast tumors using The Cancer Genome Atlas (TCGA) dataset confirmed significantly higher levels of methylation of the promoter in basal-like breast tumors compared to all other subtypes. Furthermore, inhibition of CpG methylation with 5-aza-CdR increases miR-29c expression in basal-like breast cancer cells. Flourescent In Situ Hybridization (FISH) revealed chromosomal abnormalities at miR-29c loci in breast cancer cell lines, but with no correlation between copy number variation and expression of miR-29c. Our data demonstrated that dysregulation of miR-29c in basal-like breast cancer cells may be in part driven by methylation at CpG sites. Epigenetic control of the miR-29c promoter by epigenetic modifiers may provide a potential therapeutic target to overcome the aggressive behavior of these cancers.

UR - http://www.scopus.com/inward/record.url?scp=84951325551&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84951325551&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0142224

DO - 10.1371/journal.pone.0142224

M3 - Article

C2 - 26539832

AN - SCOPUS:84951325551

VL - 10

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 11

M1 - e0142224

ER -